NeutriSci International Inc.
NRXCF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $458 | $81 | $75 | $97 |
| % Growth | 465.9% | 8.5% | -22.8% | – |
| Cost of Goods Sold | $501 | $101 | $80 | $94 |
| Gross Profit | -$43 | -$21 | -$6 | $3 |
| % Margin | -9.5% | -25.4% | -7.9% | 3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $600 | $1,251 | $1,706 | $1,420 |
| SG&A Expenses | $596 | $1,323 | $1,911 | $1,649 |
| Sales & Mktg Exp. | -$4 | $72 | $205 | $230 |
| Other Operating Expenses | $51 | $45 | $27 | $5 |
| Operating Expenses | $647 | $1,368 | $1,938 | $1,654 |
| Operating Income | -$690 | -$1,503 | -$1,944 | -$1,651 |
| % Margin | -150.8% | -1,857.6% | -2,607.2% | -1,710.7% |
| Other Income/Exp. Net | -$80 | -$69 | -$8 | $37 |
| Pre-Tax Income | -$771 | -$1,572 | -$1,953 | -$1,613 |
| Tax Expense | $0 | $0 | $0 | $1 |
| Net Income | -$771 | -$1,572 | -$1,953 | -$1,613 |
| % Margin | -168.4% | -1,943.5% | -2,618.3% | -1,670.7% |
| EPS | -0.005 | -0.01 | -0.014 | -0.014 |
| % Growth | 53.5% | 27.2% | 2.2% | – |
| EPS Diluted | -0.005 | -0.01 | -0.014 | -0.014 |
| Weighted Avg Shares Out | 166,151 | 158,585 | 143,378 | 116,021 |
| Weighted Avg Shares Out Dil | 166,151 | 158,585 | 143,378 | 116,021 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $1 | $1 | $1 |
| Depreciation & Amortization | $37 | $45 | $27 | $5 |
| EBITDA | -$733 | -$1,526 | -$1,924 | -$1,607 |
| % Margin | -160.2% | -1,886.5% | -2,579.9% | -1,664.3% |